How will your role help us transform hope into reality? Reporting to the Chief Commercial Officer and siting on the Commercial Leadership Team, the Head of Forecasting and Advanced Analytics will be responsible for leading a team that generates and applies critical insights to drive optimal performance across the Blueprint Medicines inline portfolio, with a goal of positively impacting patient lives. You and the team will drive the understanding and predictive forecasting of the market opportunity for inline products. You will collaboratively develop and execute against an insights agenda aligned with brand and corporate needs and will be a critical stakeholder of the commercial team. Additionally, you will have experience with modeling, facility taking business questions and formulating them into analytics questions and answers, and strong intuition to sense check outputs and/or pursue new lines of analysis that lead to business impact. What will you do? Leads forecasting, commercial analytics, market research, and claims data insight generation for inline products. In tandem with the brand and Commercial Leadership Team, builds the forecast and offers performance insights for inline products, and leads innovative analyses to answer critical performance questions. Regularly shares performance narrative and KPIs across several cross-functional forums and with executive stakeholders. Proactively leads ad hoc analyses to answer questions in real-time and anticipates needs of partners across the organization. Responsible for coordinating and overseeing all US and global market research for marketed products. Oversees the LRP process for marketed products while working closely with finance and EU teams. Integrates with brand team to ensure revenue and product growth is aligned with brand strategies and deliverables. Experience with modeling, facility taking business questions and formulating them into analytics problems, strong intuition to sense check outputs and/or pursue new lines of analysis that lead to business impact Uses AI and other advanced analytics to project the future growth and changes in the market. Uses predictive analytics to support patient finding as well as enhance targeting and field effectiveness. Builds and leads a team; coaches and develops people directly reporting to them and in other departments. Working collaborative with cross-functional partners, establishes and executes processes for revenue and P&L management, business planning and reporting. What minimum qualifications do we require? 9 years of relevant experience in biotech/pharma forecasting, analytic and/or market research, consulting, or a related field preferred. Bachelor’s degree required; MBA or PhD, or other advanced degree preferred. What additional qualifications will make you a stronger candidate? At least 5 years of direct people management experience preferred. Demonstrated ability to operate in a fast-paced, high-growth environment. Experience in specialty markets, particularly allergy/immunology, oncology or rare diseases, preferred. Prior work within a biotech/pharma company. High degree of familiarity and previous experience working with a range of commercial data sources for specialty or limited distribution products, including SPP, patient-level data, and claims data. Highly analytical; uses data to support decisions; can clearly communicate complex ideas to diverse audiences. Ability to operate as a “player/coach”; comfort executing work as well as leading and coaching others to do so. Excellent executive presence; can clearly communicate complex information effectively to executive leaders and external audiences. Comfortable with ambiguity; can build processes and drive towards implementation in a fast-paced and evolving environment. Highly collaborative; can comfortably work with a variety of colleagues and stakeholders to gain alignment. Relentlessly externally focused; keeps the patient at the center when making decisions. Excellent written and oral communication skills; comfortable delivering presentations to a wide range of stakeholders. Commitment to our Core Values: Patients First, Thoughtfulness, Urgency, Trust, Optimism Why Blueprint? At Blueprint Medicines, we achieve impactful results because of our global crew of compassionate innovators – the Blue Crew. Through authentic relationships and our collective entrepreneurial spirit and action, we are each empowered to take ownership and execute with strategic prioritization. We put trust in our people to break through norms and conventions using their individual strengths and insights, which drives our success. This is the place where the extraordinary becomes reality, and you could be part of it. Patients are waiting. Are you ready to make the leap? Equity, Diversity, Inclusion and Affirmative Action At Blueprint Medicines, we foster a culture of equity, diversity and inclusion. A proud Equal Employment Opportunity and Affirmative Action employer, we consider all qualified applicants without regard to race, color, sex, gender identity or expression, sexual orientation, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, or any other characteristic protected under applicable law. We are also an E-Verify Employer. We will make reasonable accommodations, absent undue hardship, for qualified individuals with known disabilities. If you are an individual with a disability in need of an accommodation with the application or recruiting process, please reach out to TotalRewardsblueprintmedicines.com. For more information, please see our EEO-AA Policy Statement , the EEO Know Your Rights Poster , as well as our Pay Transparency Statement . Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines, including bringing our medicine to patients with systemic mastocytosis (SM) in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases including SM and chronic urticaria, breast cancer and other solid tumors. LI-Hybrid LI-AQ1